インフォショップ ホームへ 株式会社グローバルインフォメーション
サイトマップ


その他のカテゴリ

エスピコム(Espicom) 総代理店
English Korean Chinese
【 英文年間情報 】

北欧地域における医薬品市場の見通し

The Outlook for Pharmaceuticals in Northern Europe

商品コード : 46322 Espicom Business Intelligence
発行回数: 4 回 / 年
発行 : Espicom Business Intelligence
電話でのお問い合わせ
価格情報
概要 原文目次
※この商品は英文にてご提供いたします。

Abstract

Each country report in this regional collection provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. For each country you will receive 4 completely updated reports sent quarterly, plus comprehensive report sent annually.

These reports analyse the issues

The Outlook for Pharmaceutical Markets in Northern Europe is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include 4 completely updated reports sent quarterly, plus comprehensive report sent annually. There are over 65 markets covered in the worldwide series.

7 Key Markets Covered!

  • Denmark
  • Estonia
  • Finland
  • Latvia
  • Lithuania
  • Norway
  • Sweden

Table of Contents

DENMARK BACKGROUND DATA

  • GEOGRAPHY
  • POLITICAL OVERVIEW
  • ECONOMIC OVERVIEW
    • Gross Domestic Product, 2007-2012
  • POPULATION
    • Population Trends, 2005-2007
    • Population by Region & Gender, 2006
    • Population by Age & Gender, 2006
  • DEMOGRAPHIC INDICATORS
    • Demographic Indicators, 2000-2006
  • MORTALITY
    • Causes of Death, 2005
  • MORBIDITY
  • Cancer Incidence
    • Most Common Types of Cancer Among Male (New Cases), 2003
    • Most Common Types of Cancer Among Female (New Cases), 2003
  • HIV / AIDS
    • Diagnosed Cases of AIDS, 1999-2005
    • HIV Cases by mode of transmission, 2000-2005

CHARTS

  • Map of Denmark
  • Population by Age, 2006 (%)
  • Causes of Death, 2005 (%)

DENMARK HEALTHCARE SYSTEM

  • ORGANISATION & ADMINISTRATION
  • HEALTH EXPENDITURE
  • HOSPITAL SERVICES
  • Hospital Resources
    • Hospitals by Type, 2004
    • Hospitals by Region, 2004
    • Hospital Beds by Region, 1993-2004
    • Hospital Beds by Specialty, 2004
    • Hospital Beds by Specialty, 1996-2000
    • Hospital activity by Year, 2000-2005
    • Hospital Activity Summary by ICD-10 Classification and Year, 2002-2005
    • Hospital Patients, 2003-2005
    • Hospital Admissions, 2003-2005
    • Average length of Stay, 2002-2003
  • Private Hospitals
  • AMBULATORY CARE
    • Outpatient Activity by Region, 2002-2004
    • Outpatient Activity by Specialty, 2002-2004
  • MEDICAL PERSONNEL
    • Persons Employed in the Hospital Sector, 1995-2004
    • Primary Sector Medical Personnel, 1990-1999

CHARTS

  • Central Government Expenditure on Health, 2001-2005

DENMARK ACCESSING THE PHARMACEUTICAL MARKET

  • INTRODUCTION
  • REGULATORY ENVIRONMENT
    • Centralised Procedure
    • The EMEA
    • Mutual Recognition Procedure
  • Pharmaceutical Registration
    • Clinical Trials
  • Advertising
  • Patent Protection & Intellectual Property Rights
    • Supplementary Protection Certificates
  • Pricing and Reimbursement
    • Pricing
    • Price Index
    • The Price List of Proprietary Medicinal Products
    • DKMAnet Prices and Packages
    • Generic substitution
    • Reimbursement
  • Relationship Between Annual Consumption and Pharmaceutical Reimbursement, 2007
  • DISTRIBUTION CHANNELS
    • Pharmacies, 1990 - 2004
  • Distributors
    • Amgros
    • Dupharma
    • Missionpharma
  • Parallel Imports
  • DOMESTIC PRODUCTION
    • Domestic Pharmaceutical Manufacturing Turnover, 2001-2006
  • Trade Associations
  • Domestic Producers
    • ALK-Abelló
    • Genmab A/S
    • Hexal A/S
    • Leo Pharma
    • Lundbeck A/S
    • Novo Nordisk
    • PharmaDanica
    • Pharmexa
  • Research & Development
    • Pharmaceutical Research & Development Expenditure by Lif' s Member Companies, 1990-2000 (DKr Million)
  • DIRECTORY
  • Government Organisations
  • Trade Associations

ESTONIA BACKGROUND DATA

  • GEOGRAPHY
  • POLITICAL OVERVIEW
  • ECONOMIC OVERVIEW
    • Economic Indicators, 2004-2011
  • POPULATION
    • Population, 1990-2006
    • Population by County, 2000-2006
    • Population by Age, 2000-2006 (%)
  • DEMOGRAPHIC INDICATORS
    • Principal Demographic Indicators, 1997-2005
  • MORTALITY
    • Causes of Death, 1999-2005
    • Causes of Death, 2005
    • Infant Mortality by Sex and Place of Residence, 2001-2005
    • Infant Mortality by Cause, 2003
  • MORBIDITY
    • Selected Notified Infectious Diseases, 1995-2001 (Per 100,000 Population)
      • Tuberculosis
    • Tuberculosis Cases, 1990-2004
      • Cancer
    • New Cancer Cases, 1995-2003
      • HIV/AIDS
    • New Cases of HIV, 1996-2005

CHARTS

  • Map of Estonia
  • Population by Age Group, 2006 (%)
  • Birth, Death and Infant Mortality Rates, 1997-2005
  • Leading Causes of Death, 2005 (%)

ESTONIA HEALTHCARE SYSTEM

  • ORGANISATION & ADMINISTRATION
  • HEALTH EXPENDITURE
    • Health Expenditure by Source, 1999-2004 (Ekr 000)
    • Health Expenditure by Source, 1999-2004 (%)
    • Health Expenditure by Source, 2004 (Ekr 000)
    • Public Health Expenditure, 2004 (Ekr 000)
    • Private Health Expenditure, 2004 (Ekr 000)
  • HOSPITAL SERVICES
  • Hospital Resources
    • Hospital Trends, 1995-2004
  • Hospital Activity
    • Hospital Activity, 1996-2004
    • Hospital Admissions by Specialty, 1995-2001
    • Average Length of Stay by Specialty, 1995-2001 (Days)
    • Bed Occupancy by Specialty, 1995-2001 (%)
    • Bed Turnover by Specialty, 1995-2001
  • Private Hospitals
    • Private Hospital Trends, 1994-2004
    • Private Hospitals & Beds by County, 2001-2004
  • AMBULATORY CARE
    • Outpatient Visits Trends, 1996-2004
    • Outpatient Visits by County, 2004
  • MEDICAL PERSONNEL
    • Medical Personnel Trends, 1996-2004
    • Doctors by Specialty, 1990-2001
    • Doctors by County, 1999-2004
    • Other Medical Personnel, 1995-2004

CHARTS

  • Health Expenditure by Source, 2004 (%)

ESTONIA ACCESSING THE PHARMACEUTICAL MARKET

  • INTRODUCTION
  • REGULATORY ENVIRONMENT
  • Pharmaceutical Registration
    • Marketing Authorisation
    • Clinical Trials
    • Clinical Trials, 1991-2005
  • Advertising
  • Patent Protection & Intellectual Property Rights
  • Pricing and Reimbursement
    • Pharmaceutical Reimbursement Rates and Co-payments, 2001
  • DISTRIBUTION CHANNELS
    • Leading Wholesalers by Market Share (%), 2000-2005
    • Sales of Medicinal Products in Retail and Hospital Pharmacies (Ekr millions)
  • Distributors
    • Berren OU
    • Magnum Pro Med Ltd.
    • AS Oriola
    • Tamro Eesti AS
    • TopMed AS
  • TRADE FAIRS
  • Medifar
  • DOMESTIC PRODUCTION
  • Domestic Producers
    • Tallinna Farmaatsiatehase AS
  • DIRECTORY

FINLAND BACKGROUND DATA

  • GEOGRAPHY
  • POLITICAL OVERVIEW
  • ECONOMIC OVERVIEW
    • Estimated/Projected GDP 2004-2011
  • POPULATION
    • Population, 1990-2005
    • Population by Region, 2000-2005
  • DEMOGRAPHIC INDICATORS
    • Demographic Indicators, 1995-2005
  • MORTALITY
    • Registered Causes of Death, 2001-2005
  • MORBIDITY
    • Reported Incidence of Infectious Diseases, 2002-2006
    • Reported Cases of HIV & AIDS, and AIDS Related Deaths, 1995-2006

CHARTS

  • Map of Finland
  • Population by Age Group, 2005 (%)
  • Leading Causes of Death, 2005 (%)

FINLAND HEALTHCARE SYSTEM

  • ORGANISATION & ADMINISTRATION
  • HEALTH EXPENDITURE
    • Health Expenditure at Current Prices, 1985-2004 (million euros)
    • Health Expenditure by Category, 1998-2004 (million euros)
    • Outpatient Expenditure by Category, 1994-2000 (million euros)
  • HOSPITAL SERVICES
    • Hospitals by Type, 1998
    • Hospital Beds, 1993-2003
  • Hospital Activity
    • Inpatient Activity Summary, 1990-2004
    • Average Length of Stay by Healthcare Provision, 2003 (days)
    • Average Length of Stay by Hospital Type, 1992-2001
    • Average Length of Stay by Speciality, 1995-2003
    • Inpatient Primary Healthcare Patient Numbers, 1997-2003
    • Inpatient Primary Healthcare Patient Days by Significant Disease Groups, 1997-2003
    • Inpatient Specialised Healthcare Patient Numbers, 1997-2003
    • Inpatient Specialised Healthcare Patient Days, 1997-2003
    • Average Length of Stay in Specialised Healthcare by Disease Classification, 1997-2003 (Days)
  • Hospital Procedures
    • Patient Numbers for Common Operations and Procedures, 1997-2003
    • Care Days for Operations and Procedures, 1997-2003
    • Average Length of Stay for Common Operations and Procedures, 1997-2003 (days)
  • AMBULATORY CARE
    • Outpatient Visits to Health Centres by Type of Activity, 1998-2003
    • Outpatient Visits to Specialist Outpatient Centres by Specialty, 1999-2003
    • Dental Visits, 1997-2003
  • MEDICAL PERSONNEL
    • Healthcare Professionals of Working Age, 2002-2003
    • Healthcare Professionals of Working Age, 1995-2003
    • Physicians of Working Age by specialty, 2004

CHARTS

  • Health Expenditure by Category, 2004 (%)
  • Health Expenditure, 1985-2004
  • Total Admissions and ALOS, 1990-2004

FINLAND ACCESSING THE PHARMACEUTICAL MARKET

  • INTRODUCTION
  • REGULATORY ENVIRONMENT
    • European Union Regulatory Reforms
    • Centralised Procedure
    • The EMEA
    • Mutual Recognition Procedure
  • Pharmaceutical Registration
  • Advertising
  • Patent Protection & Intellectual Property Rights
    • Supplementary Protection Certificates
  • Pricing and Reimbursement
    • Reimbursement
    • Drug Price Structure
  • DISTRIBUTION CHANNELS
    • Pharmacies, 1980-2005
  • Distributors
  • DOMESTIC PRODUCTION
    • Summary of Domestic Production, 2000-2005 (euro thousands)
    • Summary of Manufacturing Facilities and Employees, 2000-2005
  • Trade Associations
    • PIF member companies, 2006
  • Domestic Producers
  • Research & Development
  • DIRECTORY

CHARTS

  • Average Drug Price Structure, 2004

LATVIA BACKGROUND DATA

  • GEOGRAPHY
  • POLITICAL OVERVIEW
  • ECONOMIC OVERVIEW
  • POPULATION
    • Population, 1994-2006
    • Population by Area, 1994-2006
    • Population of Major Cities, 2001-2006
    • Population by Age Group, 2000-2006
  • DEMOGRAPHIC INDICATORS
    • Demographic Indicators, 1997-2005
  • MORTALITY
    • Leading Causes of Death, 2005
    • Leading Causes of Death, 2000-2004
      • Infant Mortality
    • Leading Causes of Infant Death, 2002-2005
  • MORBIDITY
    • Communicable/infectious diseases
    • Reported Infectious Diseases, 2000-2005
      • Cancer
    • Cancer Incidence, 1998-2005
      • Tuberculosis
    • TB Cases, 1998-2005
      • HIV/AIDS
    • Cumulative Reported Cases of HIV and AIDS, 1999-2005

CHARTS

  • Map of Latvia
  • Population by Age, 2006 (%)
  • Causes of Death, 2005 (%)

LATVIA HEALTHCARE SYSTEM

  • ORGANISATION & ADMINISTRATION
  • Public sector
  • Private sector
  • HEALTH EXPENDITURE
  • HOSPITAL SERVICES
    • Hospitals and Beds, 2000-2005
    • Hospital Beds by Regional Sickness Fund, 2000-2001
    • Beds by Specialty and Operator, 2002
    • Hospital Beds by Specialty, 1999-2005
  • Hospital Activity
    • Hospital Activity, 1998-2005
      • Surgical procedures
    • Surgical Operations Performed, 1999-2004
  • AMBULATORY CARE
    • Outpatient Facilities, 2000-2005
    • Outpatient Visits, 1998-2005
  • MEDICAL PERSONNEL
    • Physicians by Specialty, 2001-2005
    • Personnel by Employer and Region, 2001
    • Other Medical Staff, 2000-2005

LATVIA ACCESSING THE PHARMACEUTICAL MARKET

  • INTRODUCTION
  • REGULATORY ENVIRONMENT
  • Pharmaceutical Registration
  • Advertising
  • Patent Protection & Intellectual Property Rights
  • Pricing and Reimbursement
  • DISTRIBUTION CHANNELS
    • Hospital purchasing
  • Distributors
    • Farmserviss
    • Magnum Medical
    • Mepha Latvia
    • Recipe Plus
    • Tamro SIA
  • DOMESTIC PRODUCTION
  • Trade Associations
    • Latvian Chamber of Commerce & Industry
  • Domestic Producers
    • Kalceks
    • Grindex
    • Olainfarm
  • DIRECTORY
  • Healthcare Organisations
  • Trade Associations

LITHUANIA BACKGROUND DATA

  • GEOGRAPHY
  • POLITICAL OVERVIEW
  • ECONOMIC OVERVIEW
    • Economic Indicators, 2004-2011
  • POPULATION
    • Population, 1990-2006 (000s)
    • Population by Area, 1990-2006 (000s)
  • DEMOGRAPHIC INDICATORS
    • Principal Demographic Indicators, 1998-2005
  • MORTALITY
    • Causes of Death, 1995-2004
      • Infant mortality
    • Infant Deaths by Cause, 2004
  • MORBIDITY
    • Infectious diseases
    • Selected Notifiable Diseases, 1999-2004
      • HIV & AIDS
    • Reported Incidence of and Deaths from HIV & AIDS, 1995-2004
      • Cancer
    • Incidence and Prevalence of Malignant Neoplasms, 1997-2004
    • New Cancer Cases by Leading Site, 2001

CHARTS

  • Map of Lithuania
  • Population by Age Group, 2006 (%)
  • Birth & Death Rates, 1995-2005
  • Causes of Death, 2004 (%)

LITHUANIA HEALTHCARE SYSTEM

  • ORGANISATION & ADMINISTRATION
  • HEALTH EXPENDITURE
    • Health Expenditure, 1999-2004 (LTL millions)
    • CHIF Expenditure by Type, 2003
  • HOSPITAL SERVICES
  • Hospital Resources
    • Hospitals & Beds, 1996-2004
    • Hospitals by Specialty, 2003-2004
    • Hospital Beds by Specialty, 1996-2001
  • Hospital Activity
    • Hospital Activity, 1996-2004
    • Discharges of Adults by Diagnosis, 1995-2004 (Per 1,000 Population)
    • Discharges of Children by Diagnosis, 1995-2004 (Per 000 Population)
      • Surgical Procedures
    • Surgical Procedures in Hospitals, 1997-2004
  • AMBULATORY CARE
    • Outpatient Facilities, 2003-2004
    • First Aid Services, 1995-2001
    • Doctor and Dentist Visits, 1996-2004
  • MEDICAL PERSONNEL
    • Medical Personnel, 1995-2004
    • Doctors by Specialty, 2000-2003

CHARTS

  • Health Expenditure by Source, 2004 (%)

LITHUANIA ACCESSING THE PHARMACEUTICAL MARKET

  • INTRODUCTION
  • REGULATORY ENVIRONMENT
  • Pharmaceutical Registration
    • Marketing Authorisation
    • Marketing Authorisation Applications & Renewals, 2004-2005
    • Evaluated Marketing Authorisation Applications & Renewals, 2004-2005
      • Post-market Surveillance
      • Quality Control
      • Clinical Trials
  • Advertising
  • Patent Protection & Intellectual Property Rights
  • Pricing & Reimbursement
  • DISTRIBUTION CHANNELS
  • Distributors
    • Asotra
    • Armedika
    • Armila
    • Entafarma
    • Tamro
    • K. Backevicius Personal Enterpise (Korys)
  • TRADE FAIRS
  • DOMESTIC PRODUCTION
  • Domestic Producers
    • Sanitas
    • Sanitas' Sales, 1998-2005 (LTL millions)
  • DIRECTORY
  • Government Organisations
  • Trade Associations

NORWAY BACKGROUND DATA

  • GEOGRAPHY
  • POLITICAL OVERVIEW
  • ECONOMIC OVERVIEW
  • POPULATION
    • Population, 1994-2006
    • Population by County, 2004-2006
  • DEMOGRAPHIC INDICATORS
    • Demographic Indicators, 1999-2005
  • MORTALITY
    • Causes of Death, 2001-2003
    • Causes of Death 2004
  • MORBIDITY
    • Individually Notified Cases of Infectious Diseases, 2000-2005
      • Tuberculosis
    • Notified Cases of Tuberculosis, 1995-2004
      • Cancer
    • New Cases of Cancer by Primary Site and Sex, 2005
      • HIV/AIDS
    • HIV /AIDS cases, 1984-2005

CHARTS

  • Map of Norway
  • Population by Age Group, 2006 (%)

NORWAY HEALTHCARE SYSTEM

  • ORGANISATION & ADMINISTRATION
  • HEALTH EXPENDITURE
    • Health Expenditure by Function of Care, 2001-2006 (NOK millions)
    • Health Expenditure by function and Source of Funding, 2004 (%)
  • HOSPITAL SERVICES
    • Number of Health Institutions, 1998
    • Number of Beds by Type of Institution, 2000-2004
    • Beds in Somatic Hospitals by Specialty, 1995-2000
      • Elderly Care Beds
    • Beds in Institutions for the Aged, 1999-2004
  • Hospital Activity
    • Patient Activity in Healthcare Institutions, 1999-2004
    • Discharges from Somatic Hospitals by Diagnosis, 2005
    • Discharges from General Hospitals by Diagnosis, 2002-2005
      • Day Cases
    • General Hospital Day Cases, 2006
    • General Hospital Day Cases, 2002-2006
  • AMBULATORY CARE
    • Hospital Outpatient Care
    • Outpatient Consultations, 2004-2006
  • MEDICAL PERSONNEL
    • Physicians by Specialty, June 2005
    • Dentists & Other Dentistry Staff, 2003-2004

NORWAY ACCESSING THE PHARMACEUTICAL MARKET

  • INTRODUCTION
  • REGULATORY ENVIRONMENT
  • Pharmaceutical Registration
    • Centralised Procedure
    • The EMEA
    • Mutual Recognition Procedure
  • Patent Protection & Intellectual Property Rights
  • Pricing and Reimbursement
    • Pharmacoeconomic Analyses
  • DISTRIBUTION CHANNELS
  • Distributors
    • Holtung AS
    • Norsk Medisinaldepot AS
    • Tamro Distribution AS
  • Parallel Imports
    • Parallel Imported Drug Sales, 1995-2004
  • DOMESTIC PRODUCTION
  • Trade Associations
  • Domestic Producers
  • Research & Development
    • R&D Expenditure, 1995-2005
  • DIRECTORY

SWEDEN BACKGROUND DATA

  • GEOGRAPHY
  • POLITICAL OVERVIEW
  • ECONOMIC OVERVIEW
    • Gross Domestic Product, 2007-2012
  • POPULATION
    • Population by County, 2005-2006
  • DEMOGRAPHIC INDICATORS
    • Demographic Indicators, 1998-2006
  • MORTALITY
    • Registered Causes of Death, 2000-2003
  • MORBIDITY
    • Leading Notifiable Infectious Diseases, 1998-2004
      • Cancer
    • Cancer, Reported Cases by Site, 2002-2004
      • HIV/AIDS
    • HIV/AIDS Cases, 1990-2005

CHARTS

  • Map of Sweden
  • Population by Age Group, 2005 (%)
  • Leading Causes of Death, 2003 (%)

SWEDEN HEALTHCARE SYSTEM

  • ORGANISATION & ADMINISTRATION
  • HEALTH EXPENDITURE
    • Health Expenditure by Sector, 2000-2005 (SEK million)
  • County Council Financing
  • Patient Fees
  • HOSPITAL SERVICES
  • Hospital Resources
    • Public Hospital Trends, 1997-2005
    • Public Hospitals by Type, 1999
    • Public Hospital Beds by Type, 1995-2003
    • Public Hospital Beds by Specialty, 2002 & 2003
    • Public Hospital Beds by Region & Type, 2003
  • Hospital Activity
    • Admissions
    • Inpatient Admissions by Disease, 2001-2005
    • Inpatient Admissions by Sex and Disease, 2005
      • Average Length of Stay (ALOS)
    • ALOS by Hospital Type, 1994-1999 (Days)
      • Hospital Discharges
    • Discharges by Hospital Type, 1994-1999 (000s)
    • Bed Days by Hospital Type, 1996-1999 (000s)
  • AMBULATORY CARE
    • Outpatient Visits to Doctors by Sector & County, 1999 (000s)
      • Dental Care
    • Public Sector Dental Care, 1990-1998
  • MEDICAL PERSONNEL
    • Doctors, 1990-2020
    • Public Sector Medical Personnel 1999-2003
    • Doctors by County, 2005
    • Doctors by Specialty, 2005
    • Other Medical Personnel, 1997-2000

SWEDEN ACCESSING THE PHARMACEUTICAL MARKET

  • INTRODUCTION
  • REGULATORY ENVIRONMENT
  • National Procedure
  • European Union Regulatory Reforms
  • Marketing Authorisations
  • Registration Fees
    • Market Authorisation Fees
    • Marketing Authorisation Fees (SEK)
      • Annual Registration Fees
    • Annual Registration Fees (SEK)
      • Labelling & Packaging
      • Post-Marketing Surveillance
      • Clinical Trials
  • Pharmaceutical Product Approvals
    • Approved Pharmaceutical Products, 1985-2005
    • Approved New Chemical Entities and Average Processing Period, 1985-2005
  • Patent Protection & Intellectual Property Rights
  • Pricing and Reimbursement
    • Criteria for reimbursement
    • Cost effectiveness
    • Appealing Decisions
  • Generic Substitution
    • Price decline for off-patent drugs
  • DISTRIBUTION CHANNELS
    • VAT and Import Duty
    • Pharmacies
    • Pharmacies, 1980-2005
  • Distributors
    • Kronans Droghandel AB (KD AB)
    • Tamro Sweden
  • Wholesale Distribution Authorisation
  • Parallel Imports
    • Parallel Imported Pharmaceutical Market, 1997-2005
  • DOMESTIC PRODUCTION
    • Domestic Production, 2001-2004 (SEK 000s)
    • Leading Pharmaceutical Manufacturers by Sales, 2005
  • Trade Associations
  • Domestic Producers
  • Multinationals
  • Research & Development
  • DIRECTORY
  • Government Organisations
  • Trade Associations

CHARTS

  • R&D Clinical Costs, 1999-2005 (SEK billions)
概要 原文目次
※この商品は英文にてご提供いたします。
【 英文年間情報 】
北欧地域における医薬品市場の見通し
The Outlook for Pharmaceuticals in Northern Europe
発行回数: 4 回 / 年
電話でのお問い合わせ
この商品について問い合わせる
この商品のサンプル(抜粋)を依頼する
価格

※ドル建て価格の商品のお支払いは、銀行レート (TTS: 107.78) 換算による円建てのご請求書にて承ります。

US $ 3,995 換算 -> ¥ 430,581 (税抜) Hard Copy
US $ 3,995 換算 -> ¥ 430,581 (税抜) PDF by E-mail (Single User License)
商品コード : 46322
関連する商品をキーワードで検索する